New drug candidate that reprograms the immune system shows promise as a brain cancer treatment

MedicalXpress | ماي 13, 2026

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for glioblastoma, the most aggressive and most common type of primary brain cancer in adults. In preclinical research, published in Science Translational Medicine, scientists have shown that the newly developed drug candidate can eliminate deadly glioblastoma tumors, which typically resist standard treatments and often recur rapidly, even after surgery, radiation, and chemotherapy.